ERBB2 and breast carcinoma: Breast cancer (BCa) is currently the second leading cause of cancer-related deaths in women worldwide [1] and is routinely categorized into different subtypes based on the amplification of human epidermal growth factor receptor 2 (HER2) and expression of estrogen receptor (ER) and progesterone receptor (PR) [2].